premenopausal
Showing 26 - 50 of 1,111
Induced Alopecia Among Postmenopausal and Premenopausal Female
Recruiting
- Breast Carcinoma
- Electronic Health Record Review
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Systemic Lupus Erythematosus Trial (simvastatin, Comparator: Placebo)
Terminated
- Systemic Lupus Erythematosus
- simvastatin
- Comparator: Placebo
- (no location specified)
Feb 7, 2022
Nausea Trial in San Antonio (Bremelanotide, Zofran, Placebo)
Completed
- Nausea
- Bremelanotide
- +2 more
-
San Antonio, TexasICON Early Phase Serrvices, LLC
Mar 31, 2022
Ovarian Reserve in Premenopausal Breast Cancer
Terminated
- Premenopausal Breast Cancer
- Breast Cancer
-
Dublin, Dublin 18, Ireland
- +9 more
Jan 14, 2022
Hypoactive Sexual Desire Disorder Trial in Seoul (Bremelanotide, Placebo)
Recruiting
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 15, 2022
To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast
Active, not recruiting
- To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast Cancer After 5 Years
- OFS continues to use group after 5 years
- Immunohistochemical detection of HR status
-
Wuhan, Hubei, ChinaWu Xinhong
Sep 17, 2023
Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)
Recruiting
- Breast Cancer Invasive
- Leuplin or zoladex
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 16, 2022
Ovarian Reserve in Premenopausal Early-stage Breast Cancer or
Recruiting
- Breast Cancer
- Blood draw and questionnaires
-
Basking Ridge, New Jersey
- +7 more
Jan 19, 2023
Uterine Fibroids, Endometriosis Trial (Relugolix Combination Tablet)
Not yet recruiting
- Uterine Fibroids
- Endometriosis
- Relugolix Combination Tablet
- (no location specified)
May 16, 2023
Quality of Life and Hormone Levels in Premenopausal Early Breast
Recruiting
- Early-stage Breast Cancer
-
Bologna, Italy
- +17 more
Jan 31, 2023
Menstruation Disturbances, Luteal Phase Defect Trial (Exercise+CR, Light Conditioning)
Completed
- Menstruation Disturbances
- Luteal Phase Defect
- Exercise+CR
- Light Conditioning
- (no location specified)
Oct 25, 2021
Breast Disease and Cardiovascular Disease
Completed
- Cardiovascular Diseases
- Ischemic Heart Disease
- screening mammography
- mastoplasty and breast fat excission
-
Naples, ItalyRaffaele Marfella
Sep 23, 2022
Menopause and Oral Microbiome
Recruiting
- Menopause
- Intraoral examination, saliva, dental plaque and serum collection.
-
İzmir, TurkeyEge University
Apr 17, 2022
Assessment of Brain Cognitive Impairment in Breast Cancer
Recruiting
- Breast Cancer
- +2 more
- PET/MRI, psychobehavioral tests and questionnaires, serum biomarkers and stool sample
-
Xi'an, Shaanxi, ChinaTangdu Hospital
Jul 12, 2022
Female Breast Cancer Trial in Germany
Recruiting
- Female Breast Cancer
-
Moenchengladbach, NRW, Germany
- +4 more
Mar 30, 2023
d for Lower Urinary Tract Symptoms on Sexual Function
Recruiting
- Urge Incontinence
- Urgency-frequency Syndrome
- no intervention
-
Istanbul, Arnavutkoy, TurkeyArnavutkoy State Hospital
May 20, 2022
Healthy Trial in Mannheim (Microgynon®, BI 425809)
Recruiting
- Healthy
- Microgynon®
- BI 425809
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Jan 30, 2023
Premenopausal Women Trial (Exercise)
Completed
- Premenopausal Women
- Exercise
- (no location specified)
Mar 18, 2021
Metastatic Breast Cancer Trial in Johannesburg (Palbociclib, Exemestane, Goserelin)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
-
Johannesburg, South AfricaWits Oncology center
Jul 22, 2021
Towards Early Detection of Breast Cancer in High Risk Population
Not yet recruiting
- Breast Cancer
- MRI scan
- Blood test
-
Aberdeen, Aberdeenshire, United KingdomAberdeen Biomedical Imaging Centre
Feb 24, 2022
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
Premenopausal Breast Cancer Trial in Taipei (Pembrolizumab/ Exemestane/ Leuprolide)
Recruiting
- Premenopausal Breast Cancer
- Pembrolizumab/ Exemestane/ Leuprolide
-
Taipei, TaiwanNational Taiwan University Hospital
May 6, 2021
Estrogen-receptor Positive Premenopausal Early Breast Cancer
Active, not recruiting
- Early Breast Cancer
- None intervention (observational study)
-
Aviano, Italy
- +39 more
Feb 7, 2023